EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy

Vitale Miceli iD, Mattia Emanuela Ligotti, Vincenzo Raffo iD, Silvia Lopa iD, Viviana Ippolito, Alessia Gallo iD, Nicola Cuscino iD, Simone Dario Scilabra iD, Margot Lo Pinto iD, Simone Messina, Salvatore D'Arpa, Matteo Moretti und 3 weitere

Cells · 09.06.2026 · 15 (12) · 1056

DOI: 10.3390/cells15121056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 09.06.2026. Verfasst von Vitale Miceli und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90127 Palermo, Italy. Hauptthemen laut MEDLINE: Interleukin-1beta, Osteoarthritis, Mesenchymal Stem Cells, Adipose Tissue. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis is a chronic degenerative joint disease characterized by inflammation and cartilage degradation, for which current treatments are mainly symptomatic and unable to halt disease progression. Adipose-derived mesenchymal stem cells (ASCs) represent a promising therapeutic option due to their regenerative and immunomodulatory properties, which may be further enhanced through specific priming strategies. In this study, primary human ASCs were exposed to interleukin-1 beta (IL1β), interferon-gamma (IFNγ), or hypoxic priming, and subsequently analyzed using a multi-omics approach integrating RNA sequencing, proteomics of secretome, and exosomal miRNA profiling. Differential gene expression, protein abundance, and miRNA signatures were assessed together with functional enrichment and network analyses. IL1β priming induced marked transcriptional reprogramming of ASCs, while hypoxia and IFNγ priming produced limited changes. IL1β also profoundly reshaped the ASC secretome and exosomal miRNA cargo, revealing coordinated regulation of pathways involved in immune modulation and cartilage remodeling. In contrast, the other priming conditions showed minimal and less integrated molecular effects. Overall, IL1β priming consistently generated a multi-layered molecular signature linking immunoregulatory and regenerative pathways. These findings suggest that IL1β priming enhances the functional properties of ASCs and provides mechanistic insight supporting their potential use in osteoarthritis therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-1betaOsteoarthritisMesenchymal Stem CellsAdipose TissueRegenerationImmunomodulationHumansMultiomicsMicroRNAsProteomicsInterferon-gammaExosomes

Stichwörter der Autor:innen

adipose derived mesenchymal stem cellscartilage remodelingimmunomodulationinterleukin 1 beta primingmulti-omicsosteoarthritis

Substanzen

Interleukin-1betaMicroRNAsInterferon-gamma

Autor:innen und Institutionen

  • Department of Research, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90127 Palermo, Italy.
  • Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica (Di.Me.Pre-J), Università Degli Studi di Bari, Valenzano, 70124 Bari, Italy.
  • Cell and Tissue Engineering Laboratory, IRCCS Galeazzi-Sant'Ambrogio Hospital, Via Cristina Belgioioso 173, 20157 Milan, Italy.
  • Proteomics Group of Ri.MED Foundation, Research Department, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90127 Palermo, Italy.
  • Plastic and Reconstructive Surgery and Breast Unit, La Maddalena Cancer Center, 90146 Palermo, Italy.
  • Regenerative Medicine Division, Institute for Translational Research, Università della Svizzera Italiana (USI)-Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.

ORCID-Profile: Vitale Miceli, Vincenzo Raffo, Silvia Lopa, Alessia Gallo, Nicola Cuscino, Simone Dario Scilabra, Margot Lo Pinto, Laura de Girolamo, Matteo Bulati, Alessandra Colombini

Förderung

  • European Union

Zitieren

APA

Miceli, V., Ligotti, M. E., Raffo, V., Lopa, S., Ippolito, V., Gallo, A., Cuscino, N., Scilabra, S. D., Lo Pinto, M., Messina, S., D'Arpa, S., Moretti, M., de Girolamo, L., Bulati, M., & Colombini, A. (2026). A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy. Cells, 15(12), 1056. https://doi.org/10.3390/cells15121056

Vancouver

Miceli V, Ligotti ME, Raffo V, Lopa S, Ippolito V, Gallo A, et al. A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy. Cells. 2026;15(12):1056. doi:10.3390/cells15121056

BibTeX
@article{Miceli2026,
  author = {Miceli, Vitale and Ligotti, Mattia Emanuela and Raffo, Vincenzo and Lopa, Silvia and Ippolito, Viviana and Gallo, Alessia and Cuscino, Nicola and Scilabra, Simone Dario and Lo Pinto, Margot and Messina, Simone and D'Arpa, Salvatore and Moretti, Matteo and de Girolamo, Laura and Bulati, Matteo and Colombini, Alessandra},
  title = {A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {1056},
  doi = {10.3390/cells15121056}
}
Kostenlos starten →